TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Immunovia AB
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
1,575
|
1,145
|
844 |
Financial expenses |
19,257
|
18,201
|
3,797 |
Earnings before taxes |
-309,439
|
-168,092
|
-155,966 |
EBITDA |
-154,741
|
-166,237
|
-147,565 |
Total assets |
98,681
|
300,589
|
493,809 |
Current assets |
80,511
|
115,615
|
297,102 |
Current liabilities |
29,903
|
24,086
|
32,750 |
Equity capital |
66,991
|
243,803
|
433,903 |
- share capital |
2,264
|
1,132
![]() |
1,132 |
Employees (average) |
36
|
64
|
66 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
67.9%
|
81.1%
|
87.9% |
Turnover per employee |
44
|
18
|
13 |
Profit as a percentage of turnover |
-19646.9%
|
-14680.5%
|
-18479.4% |
Return on assets (ROA) |
-294.1%
|
-49.9%
|
-30.8% |
Current ratio |
269.2%
|
480.0%
|
907.2% |
Return on equity (ROE) |
-461.9%
|
-68.9%
|
-35.9% |
Change turnover |
430
|
301
|
482 |
Change turnover % |
38%
|
36%
|
133% |
Chg. No. of employees |
-28
|
-2
|
3 |
Chg. No. of employees % |
-44%
|
-3%
|
5% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.